vs

Side-by-side financial comparison of ESCO TECHNOLOGIES INC (ESE) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

ESCO TECHNOLOGIES INC is the larger business by last-quarter revenue ($289.7M vs $208.9M, roughly 1.4× iRhythm Holdings, Inc.). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs 2.7%, a 7.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 17.3%). ESCO TECHNOLOGIES INC produced more free cash flow last quarter ($63.0M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 7.8%).

Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

ESE vs IRTC — Head-to-Head

Bigger by revenue
ESE
ESE
1.4× larger
ESE
$289.7M
$208.9M
IRTC
Growing faster (revenue YoY)
IRTC
IRTC
+9.9% gap
IRTC
27.1%
17.3%
ESE
Higher net margin
ESE
ESE
7.2% more per $
ESE
9.9%
2.7%
IRTC
More free cash flow
ESE
ESE
$48.5M more FCF
ESE
$63.0M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
7.8%
ESE

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ESE
ESE
IRTC
IRTC
Revenue
$289.7M
$208.9M
Net Profit
$28.7M
$5.6M
Gross Margin
41.4%
70.9%
Operating Margin
13.2%
1.1%
Net Margin
9.9%
2.7%
Revenue YoY
17.3%
27.1%
Net Profit YoY
22.2%
518.5%
EPS (diluted)
$1.11
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESE
ESE
IRTC
IRTC
Q4 25
$289.7M
$208.9M
Q3 25
$286.5M
$192.9M
Q2 25
$296.3M
$186.7M
Q1 25
$265.5M
$158.7M
Q4 24
$247.0M
$164.3M
Q3 24
$298.5M
$147.5M
Q2 24
$260.8M
$148.0M
Q1 24
$249.1M
$131.9M
Net Profit
ESE
ESE
IRTC
IRTC
Q4 25
$28.7M
$5.6M
Q3 25
$218.7M
$-5.2M
Q2 25
$26.1M
$-14.2M
Q1 25
$31.0M
$-30.7M
Q4 24
$23.5M
$-1.3M
Q3 24
$34.3M
$-46.2M
Q2 24
$29.2M
$-20.1M
Q1 24
$23.2M
$-45.7M
Gross Margin
ESE
ESE
IRTC
IRTC
Q4 25
41.4%
70.9%
Q3 25
45.9%
71.1%
Q2 25
41.2%
71.2%
Q1 25
41.1%
68.8%
Q4 24
39.8%
70.0%
Q3 24
40.1%
68.8%
Q2 24
39.6%
69.9%
Q1 24
38.8%
66.3%
Operating Margin
ESE
ESE
IRTC
IRTC
Q4 25
13.2%
1.1%
Q3 25
17.2%
-4.4%
Q2 25
11.2%
-10.0%
Q1 25
15.3%
-20.5%
Q4 24
11.4%
-2.5%
Q3 24
14.8%
-34.1%
Q2 24
14.3%
-15.5%
Q1 24
11.7%
-28.9%
Net Margin
ESE
ESE
IRTC
IRTC
Q4 25
9.9%
2.7%
Q3 25
76.3%
-2.7%
Q2 25
8.8%
-7.6%
Q1 25
11.7%
-19.3%
Q4 24
9.5%
-0.8%
Q3 24
11.5%
-31.3%
Q2 24
11.2%
-13.6%
Q1 24
9.3%
-34.6%
EPS (diluted)
ESE
ESE
IRTC
IRTC
Q4 25
$1.11
$0.18
Q3 25
$8.43
$-0.16
Q2 25
$1.01
$-0.44
Q1 25
$1.20
$-0.97
Q4 24
$0.91
$-0.03
Q3 24
$1.32
$-1.48
Q2 24
$1.13
$-0.65
Q1 24
$0.90
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESE
ESE
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$103.8M
$583.8M
Total DebtLower is stronger
$145.5M
Stockholders' EquityBook value
$1.6B
$152.7M
Total Assets
$2.4B
$1.0B
Debt / EquityLower = less leverage
0.09×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESE
ESE
IRTC
IRTC
Q4 25
$103.8M
$583.8M
Q3 25
$101.3M
$565.2M
Q2 25
$78.7M
$545.5M
Q1 25
$57.4M
$520.6M
Q4 24
$71.3M
$535.6M
Q3 24
$66.0M
$522.0M
Q2 24
$63.0M
$561.5M
Q1 24
$59.4M
$569.1M
Total Debt
ESE
ESE
IRTC
IRTC
Q4 25
$145.5M
Q3 25
$186.0M
Q2 25
$525.0M
Q1 25
$88.0M
Q4 24
$112.0M
Q3 24
$122.0M
Q2 24
$173.0M
Q1 24
$191.0M
Stockholders' Equity
ESE
ESE
IRTC
IRTC
Q4 25
$1.6B
$152.7M
Q3 25
$1.5B
$121.9M
Q2 25
$1.3B
$103.7M
Q1 25
$1.3B
$86.7M
Q4 24
$1.2B
$90.9M
Q3 24
$1.2B
$71.8M
Q2 24
$1.2B
$99.2M
Q1 24
$1.2B
$90.3M
Total Assets
ESE
ESE
IRTC
IRTC
Q4 25
$2.4B
$1.0B
Q3 25
$2.4B
$995.2M
Q2 25
$2.5B
$964.0M
Q1 25
$1.8B
$926.1M
Q4 24
$1.8B
$931.4M
Q3 24
$1.8B
$909.7M
Q2 24
$1.8B
$919.2M
Q1 24
$1.8B
$909.8M
Debt / Equity
ESE
ESE
IRTC
IRTC
Q4 25
0.09×
Q3 25
0.12×
Q2 25
0.40×
Q1 25
0.07×
Q4 24
0.09×
Q3 24
0.10×
Q2 24
0.14×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESE
ESE
IRTC
IRTC
Operating Cash FlowLast quarter
$68.9M
$26.2M
Free Cash FlowOCF − Capex
$63.0M
$14.5M
FCF MarginFCF / Revenue
21.7%
6.9%
Capex IntensityCapex / Revenue
2.0%
5.6%
Cash ConversionOCF / Net Profit
2.40×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$239.6M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESE
ESE
IRTC
IRTC
Q4 25
$68.9M
$26.2M
Q3 25
$109.9M
$34.9M
Q2 25
$73.7M
$27.7M
Q1 25
$24.1M
$-7.9M
Q4 24
$34.2M
$19.2M
Q3 24
$72.1M
$24.3M
Q2 24
$36.2M
$11.8M
Q1 24
$10.5M
$-52.0M
Free Cash Flow
ESE
ESE
IRTC
IRTC
Q4 25
$63.0M
$14.5M
Q3 25
$97.8M
$20.1M
Q2 25
$64.9M
$17.3M
Q1 25
$14.0M
$-17.3M
Q4 24
$29.0M
$12.4M
Q3 24
$60.9M
$15.5M
Q2 24
$27.6M
$3.4M
Q1 24
$2.0M
$-61.8M
FCF Margin
ESE
ESE
IRTC
IRTC
Q4 25
21.7%
6.9%
Q3 25
34.1%
10.4%
Q2 25
21.9%
9.3%
Q1 25
5.3%
-10.9%
Q4 24
11.7%
7.5%
Q3 24
20.4%
10.5%
Q2 24
10.6%
2.3%
Q1 24
0.8%
-46.8%
Capex Intensity
ESE
ESE
IRTC
IRTC
Q4 25
2.0%
5.6%
Q3 25
4.2%
7.7%
Q2 25
3.0%
5.6%
Q1 25
3.8%
5.9%
Q4 24
2.1%
4.2%
Q3 24
3.8%
6.0%
Q2 24
3.3%
5.7%
Q1 24
3.4%
7.4%
Cash Conversion
ESE
ESE
IRTC
IRTC
Q4 25
2.40×
4.70×
Q3 25
0.50×
Q2 25
2.83×
Q1 25
0.78×
Q4 24
1.46×
Q3 24
2.10×
Q2 24
1.24×
Q1 24
0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESE
ESE

US Government$98.0M34%
Utility Solutions Group$87.5M30%
RF Shielding And Test$58.3M20%
Commercial$45.8M16%
Related Party$1.3M0%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons